Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Veterinary antibiotic sales halved in four years
Overall sales of highest priority critically-important antibiotics (HP-CIAs) dropped an additional 19 per cent between 2017 and 2018.

Vets welcome findings from latest VARRS report 

Sales of antibiotics for use in food-producing animals have fallen by more than half in just four years, according to the latest Veterinary Antibiotic Resistance Sales and Surveillance Report (VARSS).


Published by the Veterinary Medicines Directorate (VMD), the report reveals that sales of antibiotics for food-producing animals fell by nine per cent between 2017 and 2018, and by 53 per cent since 2014.

It also shows that overall sales of highest priority critically-important antibiotics (HP-CIAs) dropped an additional 19 per cent between 2017 and 2018, and 68 per cent since 2014. 


Furthermore, clinical surveillance of antibiotic resistance revealed that most of the key pathogens that cause disease in animals remained susceptible to authorised veterinary antibiotics, including those that have been authorised for many years.

Welcoming the figures, BVA junior vice president James Russell said: “We are pleased to see further reductions in antibiotic sales in the latest VARSS report, which is a testament to the hugely successful collaborative work being carried out by vets, farmers and the industry to steward responsible antibiotic use and champion greater disease prevention measures across each of the eight livestock sectors.

“It is particularly commendable to note that sales of antibiotics in food-producing animals have fallen by an impressive 53 per cent between 2014 and 2018. Antimicrobial resistance remains a huge concern for vets, which is why we must maintain this momentum in the face of the ongoing global threat it poses to the health of animals, humans and the environment.”

He continued: “While it is vital that we continue to build upon these achievements through evidence-based, sector-specific targets to further refine, reduce or replace antibiotic use, a large part of the future changes will involve promoting high animal health and welfare through disease prevention strategies, such as increasing uptake in vaccines. Ongoing improvements in veterinary-led health planning on farms will also help to further lower antibiotic use by reducing the incidence of endemic diseases.

“BVA is committed to providing continued leadership on the issue and will continue working with our specialist divisions, RUMA, the UK One Health Coordination Group, and other key stakeholders to build upon current achievements.”

The UK’s chief veterinary officer Christine Middlemiss said: “A 53 per cent reduction in sales of antibiotics for food-producing animals in just four years is a testament to the improvements industry and the veterinary profession have made in antibiotic stewardship, training and disease control. This is a great example of how real change can be achieved when Government and industry work together including through initiatives such as the Targets Task Force chaired by RUMA (Responsible Use Of Medicines in Agriculture Alliance.


“The focus on infection prevention and control is key to reducing the need to treat with antibiotics and maintaining the UK’s world-leading standards in protecting animal health and biosecurity.”

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.